Corroborating this statement, we observed increase of LC3-I level and of LC3-II/LC3-I ratio, unchanged p62 level in 3xTg-AD versus WT mice treated with γ-secretase inhibitor (Fig. 7f, g). The gene discussed is SQSTM1; the disease is Alzheimer disease.